Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q9)Dec 31, 2023 | (Q6)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q9)Dec 31, 2022 | (Q6)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 11.85%655.62M | 19.11%1.22B | 19.26%586.18M | 36.98%1.02B | 43.55%757.25M | 46.51%491.53M | 46.96%220.64M | 31.59%747.52M | 6.01%527.52M | 6.45%335.49M |
| Operating income | 11.85%655.62M | 19.11%1.22B | 19.26%586.18M | 36.98%1.02B | 43.55%757.25M | 46.51%491.53M | 46.96%220.64M | 31.59%747.52M | 6.01%527.52M | 6.45%335.49M |
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Employee expense | -10.67%-202.84M | -21.70%-373.27M | -28.27%-183.28M | -35.77%-306.71M | -42.66%-222.76M | -36.84%-142.88M | -32.03%-64.7M | -32.10%-225.9M | -13.39%-156.15M | -18.96%-104.42M |
| Depreciation and amortization | -9.96%-116.27M | -19.23%-219.45M | -21.46%-105.74M | -41.70%-184.05M | -45.37%-134.92M | -49.39%-87.06M | -51.32%-41.42M | -14.33%-129.89M | -11.94%-92.81M | -7.95%-58.27M |
| Special items of operating profit | -12.33%-264.17M | -21.05%-496.47M | -19.29%-235.16M | -34.49%-410.14M | -40.81%-303.13M | -48.39%-197.13M | -60.77%-89.42M | -23.64%-304.95M | 1.93%-215.28M | 3.68%-132.84M |
| Operating profit | 16.68%72.35M | 5.99%130.42M | -3.82%62M | 41.80%123.05M | 52.42%96.44M | 61.34%64.46M | 38.35%25.1M | 135.80%86.78M | 10.09%63.27M | 12.57%39.95M |
| Financing cost | -10.46%-9.49M | -30.58%-19.26M | -24.60%-8.6M | -37.84%-14.75M | -35.78%-10.56M | -37.30%-6.9M | -40.84%-3.47M | -13.09%-10.7M | -12.14%-7.78M | -11.22%-5.02M |
| Earning before tax | 17.69%62.85M | 2.64%111.16M | -7.22%53.41M | 42.36%108.3M | 54.76%85.88M | 64.80%57.56M | 37.96%21.64M | 178.27%76.08M | 9.81%55.49M | 12.76%34.93M |
| Tax | -16.57%-9.77M | -1.94%-18M | 10.72%-8.38M | -169.31%-17.65M | -132.62%-13.86M | -230.66%-9.38M | -2,586.52%-3.79M | -24.83%-6.56M | 32.73%-5.96M | 52.41%-2.84M |
| After-tax profit from continuing operations | 17.89%53.09M | 2.77%93.16M | -6.54%45.03M | 30.39%90.65M | 45.39%72.02M | 50.13%48.18M | 14.84%17.85M | 214.75%69.52M | 18.85%49.53M | 28.31%32.09M |
| Earning after tax | 17.89%53.09M | 2.77%93.16M | -6.54%45.03M | 30.39%90.65M | 45.39%72.02M | 50.13%48.18M | 14.84%17.85M | 214.75%69.52M | 18.85%49.53M | 28.31%32.09M |
| Minority profit | 79.94%-140K | -1,334.38%-2.37M | -267.79%-698K | -79.87%192K | 155.37%325K | 142.23%416K | 142.12%353K | 122.22%954K | 81.28%-587K | 32.26%-985K |
| Profit attributable to shareholders | 16.40%53.23M | 5.61%95.53M | -4.26%45.73M | 31.93%90.46M | 43.04%71.69M | 44.40%47.76M | 6.81%17.5M | 159.91%68.57M | 11.85%50.12M | 24.98%33.08M |
| Basic earnings per share | 15.70%0.14 | 5.44%0.252 | -3.97%0.121 | 33.52%0.239 | 45.38%0.189 | 48.24%0.126 | 9.52%0.046 | 163.24%0.179 | 12.07%0.13 | 25.00%0.085 |
| Diluted earnings per share | 15.83%0.139 | 5.49%0.25 | -4.00%0.12 | 33.15%0.237 | 44.62%0.188 | 47.06%0.125 | 9.52%0.046 | 161.76%0.178 | 12.07%0.13 | 25.00%0.085 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Touche Tohmatsu CPA LLP | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.